DIAMETIB - DIAMETIB

Status

Not yet recruiting

Phases

Unknown

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2004-000972-15-DK

Enrollment

Registered

2004-09-23

Start date

2004-09-03

Completion date

Unknown

Last updated

2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic retinopathy

Interventions

Trade Name: Roaccutan Product Name: Isotretinoin Product Code: Unknown Pharmaceutical Form: Capsule, soft INN or Proposed INN: Isotretinoin CAS Number: 4759-48-2 Current Sponsor code: N/A Other descri

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: diabetic retinopathy Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: other eye disease

Design outcomes

Primary

Measure	Time frame
Main Objective: To determine effect on visual and vascular function;Secondary Objective: To determine effect on dark adaptation;Primary end point(s): visual acuity	—

Countries

Denmark

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026